ANIP - ANI PHARMACEUTICALS INC
This page shows which of the focused investors we track hold ANIP and how their positions changed, so you can see how much conviction the group has in the stock.
In Q4 2017 it was held by 2 managers with an aggregate reported value of $14.99M, which is 0.00% of the combined portfolio.
As of Q4 2017, 2 tracked institutional managers held ANIP (ANI PHARMACEUTICALS INC) with an aggregate reported value of $14.99M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades ANIP — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q4 2017
- Ticker
- ANIP
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Bill Miller - Miller Value Partners | 0.01% | New | 5,000 | $322K |
Other instruments
Bonds, warrants, or other non-share-class principal positions in ANIP.
| 1 | Howard Marks - Oaktree Capital Management | New | 12,719,000 | $14.67M |
Loading holder history for ANIP…